Method

Details for Australian Patent Application No. 2001248619 (hide)

Owner Oxford Biomedica (UK) Limited

Inventors Kingsman, Alan John; Mitrophanous, Kyriacos Andreou; Kotsopoulou, Ekaterini; Kim, Narry; Rohll, Jonathan

Agent Davies Collison Cave

Pub. Number AU-B-2001248619

PCT Pub. Number WO01/79518

Priority 0009760 19.04.00 GB

Filing date 18 April 2001

Wipo publication date 30 October 2001

Acceptance publication date 15 June 2006

International Classifications

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07K 14/155 (2006.01) Peptides having more than 20 amino acids

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/867 (2006.01) Mutation or genetic engineering - Retroviral vectors

Event Publications

15 June 2006 Application Accepted

  Published as AU-B-2001248619

21 September 2006 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 03 Jul 2006. Address for service in Australia - Davies Collison Cave 1 Nicholson Street MELBOURNE VIC 3000

19 October 2006 Standard Patent Sealed

22 February 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 03 Jul 2006

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001248620

2001248618